UPDATED Jun 10, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$136.84 | 1.2% | 44.3% | US$41.9b | US$153.25 | PE62x | E29.7% | 2.7% | Diversified Financials | ||
NVDA | US$121.79 | 4.6% | 196.9% | US$3.0t | US$122.95 | PE70.3x | E22.6% | 0.01% | Semiconductors | ||
NU | US$11.82 | 3.6% | 56.8% | US$56.5b | US$12.46 | PB8.3x | E37.6% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$148.48 | 1.8% | 91.7% | US$206.2b | US$205.37 | PE18.7x | E23.1% | n/a | Retail | ||
CG | US$40.70 | -3.5% | 33.7% | US$14.6b | US$48.47 | PS6.6x | E23.6% | 3.4% | Diversified Financials | ||
SMCI | US$786.86 | 2.0% | 222.2% | US$46.1b | US$1,032.47 | PE43.9x | E40.2% | n/a | Tech | ||
SYM | US$37.72 | -2.2% | -19.6% | US$21.6b | US$56.64 | PS2.6x | E131.1% | n/a | Capital Goods | ||
OWL | US$17.38 | 0.3% | 50.9% | US$24.2b | US$21.40 | PE127.2x | E90.8% | 4.1% | Diversified Financials | ||
CELH | US$66.17 | -7.4% | 32.8% | US$15.4b | US$90.49 | PE71.6x | E21.7% | n/a | Food, Beverage & Tobacco | ||
ELF | US$182.48 | -3.8% | 78.0% | US$10.2b | US$206.08 | PE80x | E21.1% | n/a | Household | ||
ALNY | US$153.47 | 2.5% | -22.3% | US$19.4b | US$220.15 | PS9.7x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
PTC | US$175.54 | 2.4% | 24.5% | US$21.0b | US$203.05 | PE73x | E22.8% | n/a | Software | ||
ZS | US$183.91 | 8.7% | 16.7% | US$27.8b | US$229.94 | PS13.7x | E51.5% | n/a | Software | ||
TER | US$143.08 | 2.5% | 28.4% | US$22.3b | US$128.91 | PE52x | E23.8% | 0.3% | Semiconductors | ||
SRPT | US$122.59 | 2.4% | -5.6% | US$11.6b | US$166.99 | PE685.8x | E37.5% | n/a | Pharmaceuticals & Biotech | ||
CHK | US$88.94 | 0.4% | 10.4% | US$11.7b | US$105.22 | PE11x | E36.2% | 2.7% | Energy | ||
NTNX | US$53.92 | -0.1% | 80.5% | US$13.2b | US$73.54 | PS6.3x | E82.6% | n/a | Software | ||
VRT | US$91.30 | -0.9% | 306.7% | US$34.2b | US$101.72 | PE84.6x | E30.3% | 0.1% | Capital Goods | ||
RYAN | US$53.68 | -5.0% | 26.4% | US$14.0b | US$58.00 | PE100.4x | E76.5% | 0.8% | Insurance | ||
SPOT | US$309.00 | -5.4% | 103.9% | US$61.3b | US$343.54 | PS4.1x | E40.6% | n/a | Media | ||
TEAM | US$162.17 | 2.7% | -10.7% | US$42.2b | US$240.61 | PS10.1x | E41.3% | n/a | Software | ||
CRWD | US$374.57 | 22.6% | 144.6% | US$91.2b | US$399.46 | PE692.4x | E34.9% | n/a | Software | ||
HUBS | US$595.92 | -2.1% | 16.2% | US$30.4b | US$674.64 | PS13.3x | E52.4% | n/a | Software |